Pachymic Acid Targets Pdia6 To Delay Mesenchymal Stem Cell Senescence Through The G6Pd/Stat3 Signaling Axis And Prevent Senile Osteoporosis
Our bodies contain special cells called mesenchymal stem cells (MSCs), which are crucial for repairing and regenerating tissues, including bone. As we get older, these MSCs can undergo a process called senescence, essentially cellular aging, where they stop dividing and lose their regenerative capabilities. This cellular aging contributes significantly to age-related conditions like osteoporosis, a disease that makes bones fragile and prone to fractures.
Scientists have identified a natural compound that shows promise in counteracting this aging process. This compound works by interacting with a specific protein inside our cells, known as PDIA6. This interaction helps to slow down the aging of MSCs.
The protective effect is achieved through a vital internal communication system within the cells, specifically the G6PD/STAT3 signaling pathway. G6PD is an enzyme that plays a key role in protecting cells from oxidative stress, a type of damage, while STAT3 is a protein involved in cell growth and survival. By modulating this pathway, the compound helps MSCs maintain their healthy, functional state, thereby supporting bone health and potentially offering a new strategy to prevent age-related bone loss.
Source: link to paper